We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Agrees to Pay $190M in Alleged Generic Delay Class Action Suit
Pfizer Agrees to Pay $190M in Alleged Generic Delay Class Action Suit
Pfizer Monday reached an agreement to settle a class action lawsuit, alleging the drugmaker attempted to improperly delay generics of its epilepsy drug Neurontin from reaching the market.